End-of-day quote
Taiwan S.E.
18:00:00 2024-05-08 EDT
|
5-day change
|
1st Jan Change
|
13.25
TWD
|
-1.49%
|
|
-4.68%
|
-12.83%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14,777
|
14,789
|
24,813
|
28,234
|
17,899
|
20,139
|
Enterprise Value (EV)
1 |
29,257
|
27,084
|
34,276
|
40,554
|
32,457
|
36,861
|
P/E ratio
|
19.7
x
|
-101
x
|
11.9
x
|
13.3
x
|
-14.4
x
|
-71
x
|
Yield
|
1.72%
|
1.8%
|
5.21%
|
4.63%
|
1.47%
|
1.32%
|
Capitalization / Revenue
|
0.24
x
|
0.24
x
|
0.48
x
|
0.34
x
|
0.25
x
|
0.28
x
|
EV / Revenue
|
0.48
x
|
0.43
x
|
0.66
x
|
0.49
x
|
0.45
x
|
0.5
x
|
EV / EBITDA
|
11.5
x
|
23.1
x
|
8.68
x
|
9.79
x
|
-50.2
x
|
23.1
x
|
EV / FCF
|
-17.6
x
|
10.5
x
|
20
x
|
-16.3
x
|
-38
x
|
-17.2
x
|
FCF Yield
|
-5.67%
|
9.5%
|
4.99%
|
-6.13%
|
-2.63%
|
-5.82%
|
Price to Book
|
0.75
x
|
0.72
x
|
0.99
x
|
0.95
x
|
0.69
x
|
0.67
x
|
Nbr of stocks (in thousands)
|
1,311,844
|
1,332,348
|
1,292,348
|
1,307,121
|
1,316,098
|
1,324,912
|
Reference price
2 |
11.26
|
11.10
|
19.20
|
21.60
|
13.60
|
15.20
|
Announcement Date
|
19-03-26
|
20-03-16
|
21-03-19
|
22-03-11
|
23-03-15
|
24-03-08
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
61,258
|
62,715
|
51,867
|
81,942
|
72,820
|
73,196
|
EBITDA
1 |
2,535
|
1,172
|
3,950
|
4,142
|
-646.6
|
1,592
|
EBIT
1 |
1,078
|
-355
|
2,273
|
2,448
|
-2,373
|
-197.5
|
Operating Margin
|
1.76%
|
-0.57%
|
4.38%
|
2.99%
|
-3.26%
|
-0.27%
|
Earnings before Tax (EBT)
1 |
948.9
|
-178.6
|
2,683
|
2,769
|
-1,722
|
-156.5
|
Net income
1 |
753.6
|
-140.4
|
2,134
|
2,147
|
-1,236
|
-282.8
|
Net margin
|
1.23%
|
-0.22%
|
4.11%
|
2.62%
|
-1.7%
|
-0.39%
|
EPS
2 |
0.5729
|
-0.1100
|
1.620
|
1.620
|
-0.9415
|
-0.2142
|
Free Cash Flow
1 |
-1,660
|
2,572
|
1,710
|
-2,487
|
-855.1
|
-2,147
|
FCF margin
|
-2.71%
|
4.1%
|
3.3%
|
-3.04%
|
-1.17%
|
-2.93%
|
FCF Conversion (EBITDA)
|
-
|
219.5%
|
43.29%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
80.12%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1942
|
0.2000
|
1.000
|
1.000
|
0.2000
|
0.2000
|
Announcement Date
|
19-03-26
|
20-03-16
|
21-03-19
|
22-03-11
|
23-03-15
|
24-03-08
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
14,480
|
12,295
|
9,463
|
12,320
|
14,558
|
16,722
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.713
x
|
10.49
x
|
2.396
x
|
2.974
x
|
-22.51
x
|
10.5
x
|
Free Cash Flow
1 |
-1,660
|
2,572
|
1,710
|
-2,487
|
-855
|
-2,147
|
ROE (net income / shareholders' equity)
|
3.67%
|
-0.7%
|
9.38%
|
7.83%
|
-4.41%
|
-1.01%
|
ROA (Net income/ Total Assets)
|
1.48%
|
-0.49%
|
3.18%
|
3.12%
|
-2.84%
|
-0.23%
|
Assets
1 |
50,762
|
28,766
|
67,113
|
68,767
|
43,491
|
121,698
|
Book Value Per Share
2 |
15.10
|
15.40
|
19.30
|
22.80
|
19.80
|
22.70
|
Cash Flow per Share
2 |
3.730
|
4.000
|
2.800
|
3.320
|
3.230
|
2.420
|
Capex
1 |
2,579
|
1,547
|
902
|
2,010
|
1,969
|
1,888
|
Capex / Sales
|
4.21%
|
2.47%
|
1.74%
|
2.45%
|
2.7%
|
2.58%
|
Announcement Date
|
19-03-26
|
20-03-16
|
21-03-19
|
22-03-11
|
23-03-15
|
24-03-08
|
|
1st Jan change
|
Capi.
|
---|
| -12.83% | 551M | | +6.15% | 105B | | -4.19% | 65.16B | | +51.90% | 42.93B | | +17.59% | 39.48B | | +6.89% | 33.27B | | +12.40% | 19.92B | | +16.25% | 17.49B | | +20.35% | 15.43B | | +9.86% | 15.09B |
Other Commodity Chemicals
|